{
  "nctId": "NCT02485418",
  "briefTitle": "Low- Dose Propofol Infusion as an Abortive Treatment for Migraine Headaches in Pediatric Patients",
  "officialTitle": "Low- Dose Propofol Infusion as an Abortive Treatment for Migraine Headaches in Pediatric Patients",
  "protocolDocument": {
    "nctId": "NCT02485418",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2017-01-06",
    "uploadDate": "2023-12-29T16:06",
    "size": 960847,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02485418/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 40,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-06",
    "completionDate": "2023-01-24",
    "primaryCompletionDate": "2023-01-24",
    "firstSubmitDate": "2015-06-04",
    "firstPostDate": "2015-06-30"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Patients with a diagnosis of migraine headache per ICHD - 3 (International Classification of Headache Disorders)\n* The subjects will have a history of migraine headaches with a presentation consistent with presentations of their headaches in the past with no indication for further investigation for secondary causes of his/her headache\n* Documented pain score greater than or equal to 6 on a 0-10 Numeric Pain Rating Scale\n* Current migraine has a greater than 24 hours duration with a current pain score of 6 or greater on a 0-10 Numeric Pain Rating Scale\n* Subjects will be scheduled for DHE infusion therapy for treatment of migraines per standard medical care\n* Patients age 7-18 years old\n* Gender: both male and female\n* Appropriate fasting interval as per ASA guidelines\n\nExclusion Criteria:\n\n* No long acting triptan therapy within 24 hours\n* No shorter acting triptan therapy within 6 hours\n* No ergot alkaloid derivatives within the last 24 hours\n* No opioid within 2 hours\n* No NSAID or acetaminophen within 1 hour of infusion\n* Use of sedative medications within 6 hours of infusion, including opioids, benzodiazepines, barbiturates\n* Headache not consistent with subject's headache history needing further work-up\n* Headache duration less than 24 hours\n* Subjects in which an intravenous line could not be secured\n* Subjects with history of significant reflux or hiatal hernia\n* Subjects with history of significant cardio pulmonary disorders\n* Patient not fasting as per ASA guidelines",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "7 Years",
    "maximumAge": "18 Years",
    "stdAges": [
      "CHILD",
      "ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Improvement in Headache Pain Score",
        "description": "Change in pain score on 0-10 Numeric Pain Rating Scale with 0 being no pain and 10 being severe pain. Subjects assessed at 10 minute intervals for the duration of the infusion with reporting of change from baseline to 60 minutes",
        "timeFrame": "Duration of propofol infusion (between 5 and 60 minutes)"
      }
    ],
    "secondary": [
      {
        "measure": "NPRS Pain Scores at 24 and 48 Hours Post Infusion",
        "description": "For subjects who experience a change in pain score or who report resolution from headache symptoms, duration of analgesia up to 48 hours after treatment,characterized by NPRS Pain scores on a scale of 0-10 with 0 being no pain and 10 being severe pain.",
        "timeFrame": "Assessments of NPRS Pain scores on a scale of 0-10 with 0 being no pain and 10 being severe pain at 24 and 48 hours after discharge from infusion"
      },
      {
        "measure": "Total Propofol Dose",
        "description": "Total dose of propofol administered (mg/kg)",
        "timeFrame": "60 minutes"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 24,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T02:29:52.537Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}